NEXGEL, Inc.

NasdaqCM:NXGL

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

💄 Cosmetics

🩺 Medical Instruments

🧴 Personal Care

💊 Pharmaceuticals

Location

United States

Market Cap

USD 20.28 M

Share Price

USD 2.65

Avg Daily Volume

47,222

Change (1 day)

-1.49%

Change (1 year)

-7.34%

Change (YTD)

-40.58%

NEXGEL, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -28.28%

NEXGEL, Inc. EBITDA Margin is -28.28% for the Trailing 12 Months (TTM) ending March 31, 2025, a -54.52% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

NEXGEL, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -62.18%, a -49.88% change year over year.
NEXGEL, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -124.07%, a -25.22% change year over year.
NEXGEL, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -165.91%, a -46.89% change year over year.
NEXGEL, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -312.41%, a 45.73% change year over year.